JAK2 and diffuse large B-cell lymphoma: The frequency of JAK2 and PD-L2 amplification in the whole cohort of DLBCL were 10.5% (8/76) and 7.9% (6/76), while both of them were 100% in PMBCL (Fig. 1a) (see Additional file 1).